期刊文献+

唑来膦酸钠对老年骨质疏松症患者疼痛评分、腰椎及髋部骨密度的影响 被引量:4

下载PDF
导出
摘要 目的探讨唑来膦酸钠对老年骨质疏松症患者疼痛评分、腰椎及髋部骨密度的影响。方法选择2016年1月~2017年1月期间在我院进行治疗的70例老年骨质疏松症患者作为研究对象,随机分为两组,各35例。对照组患者口服阿法D3胶囊+钙尔奇-D,观察组在此基础上静脉滴注唑来膦酸钠+氯化钠溶液,均持续治疗6个月。比较两组患者疼痛评分、腰椎及髋部骨密度。结果治疗前,两组患者疼痛评分、腰椎及髋部骨密度相比,差异无统计学意义(P>0.05);治疗6个月后,观察组患者疼痛评分低于对照组,腰椎及髋部骨密度水平明显高于对照组,差异有统计学意义(P<0.05)。结论针对老年骨质疏松症患者,采用唑来膦酸钠进行治疗利于降低患者疼痛评分,增加腰椎及髋部骨密度,改善治疗效果,促进患者恢复。
作者 马龙飞
出处 《海峡药学》 2018年第7期154-156,共3页 Strait Pharmaceutical Journal
  • 相关文献

参考文献8

二级参考文献70

  • 1吴宜勇.绝经后骨质疏松的判断和处理[J].中华全科医师杂志,2004,3(5):287-288. 被引量:2
  • 2Procianoy F,Prodianoy E. Orbital inflammatory disease secondaryto a single-dose administration of zoledronic acid for treatment ofpostmenopausal osteoporosis[ J]. Osteoporos Int, 2010,21(6):1057-1058.
  • 3Boonen S, Vanderschueren D, Venken K, et al. Recentdevelopments in the management of postmenopausal osteoporosiswith bisphosphonates : enhanced efficacy by enhanced compliance[J]. J Intern Med ,2008,264 (4) :315-332.
  • 4Perilli E,Le V, Ma B, et al. Detecting early bone changes usingin vivo micro-CT in ovariectomized,zoledronic acid-treated, andsham-operated rats [ J ]. Osteoporos Int,2010,21 ( 8 ) : 1371 -1372.
  • 5Scotland G,Waugh N, Royle P,et al. Denosumab for theprevention of osteoporotic fractures in post-menopausal women : aNICE single technology appraisal [ J ]. Pharmacoeconomics,2011,29(11) :951-961.
  • 6Brown JP, Morin S, Leslie W, et al. Bisphosphonates for treat- ment of osteoporosis: expected benefits, potential harms, and drug holidays [J]. Can Faro Physician, 2014,60(4) :324-333.
  • 7Reyes C, Hitz M, Prieto-Alhambra D, et al. Risks and Benefits of Bisphosphonate Therapies [ J ]. J Cell Biochem, 2016 , 117 ( 1 ) : 20-28. DOI : 10. 1002/jcb. 25266.
  • 8Lewiecki EM. Bisphosphonates for the treatment of osteoporosis: insights for clinicians [ J ]. Ther Adv Chronic Dis, 2010,1 ( 3 ) :115-128. DOI: 10. 1177/2040622310374783.
  • 9Miller PD, Jarnal SA, Evenepoel P, et al. Renal safety in patients treated with bisphosphonates for osteoporosis : a review[ J]. J Bone Miner Res, 2013 ,28 (10) :2049-2059. DOI: 10. 1002/jbmr. 2058.
  • 10Hirsehberg R. Renal complications from bisphosphonate treatment [J]. Curt Opin Support Palliat Care, 2012,6 (3) : 342-347. DOI: 10. 1097/SPC. 0b013e328356062e.

共引文献163

同被引文献52

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部